跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
SFDA
/
RELPAX 40MG TABLET
Authorized
NCE
RELPAX 40MG TABLET
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
651933a0bf07a663
Company
Unknown
Type
NCE
Approval Details
Approval Id
651933a0bf07a663
Drug Approval Sfda Name
RELPAX 40MG TABLET
Trade Name
RELPAX 40MG TABLET
Generic Name
ELETRIPTAN
Register Number
2305233704
Register Year
2017
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Blister
Package Size
3
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 25°c
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
7000000442-40-100000073665
Price
48.15
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
651933a0bf07a663
Type
NCE
Back to SFDA Approvals
RELPAX 40MG TABLET - SFDA Drug Approval Details